Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
Sponsor: Nantes University Hospital
Summary
Phase II clinical trial assessing efficacy and toxicity of pretargeted radioimmunotherapy using anti-CEAxanti-DTPA bispecific antibody and di-DTPA-131I peptide in patients with reccurrence of medullary thyroid carcinoma (abnormal calcitonin level and biomarkers doubling time lower than 5 years)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
Not specified
Start Date
2004-05
Completion Date
2011-01
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
bispecific antibody and di-DTPA-131I
Locations (11)
Centre François Baclesse
Caen, France
CHU de Grenoble
Grenoble, France
hôpital du Cluzeau
Limoges, France
CHU
Lyon, France
Hôpital de la timone
Marseille, France
CHU
Nantes, France
CHU
Rouen, France
Centre René Huguenin
Saint-Cloud, France
Centre René Gauducheau
Saint-Herblain, France
Centre Paul Strauss
Strasbourg, France
Centre Claudius Régaud
Toulouse, France